Ischemic colitis during interferon-ribavirin therapy for chronic hepatitis C: A case report

World Journal of Gastroenterology

Volumn 18, Issue 31, 2012, Pages 4233-4236

  Baik, Su Jung ^a   Kim, Tae Hun ^b   Yoo, Kwon ^b   Moon, Il Hwan ^b   Cho, Min Sun ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Ewha Womans University   (South Korea)

Author keywords

Hepatitis C; Interferon; Ischemia

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; PEGINTERFERON ALPHA2A; RIBAVIRIN; VIRUS RNA;

ABDOMINAL RADIOGRAPHY; ADULT; ANTIBIOTIC THERAPY; CASE REPORT; COLON BIOPSY; COLON ULCER; COLONOSCOPY; ENDOSCOPY; ERADICATION THERAPY; FEMALE; GENOTYPE; HELICOBACTER INFECTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTESTINE ULCER; ISCHEMIC COLITIS; LOWER ABDOMINAL PAIN; RECTUM HEMORRHAGE; REVIEW; SIGMOID; STOMACH ULCER; TREATMENT DURATION; VIRUS LOAD;

EID: 84867735746     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v18.i31.4233     Document Type: Review

References (15)

1. Sung H, Chang M, Saab S. Management of Hepatitis C Antiviral Therapy Adverse Effects. Curr Hepat Rep 2011; 10: 33-40
2. Okanoue T, Sakamoto S, Itoh Y, Minami M, Yasui K, Sakamoto M, Nishioji K, Katagishi T, Nakagawa Y, Tada H, Sawa Y, Mizuno M, Kagawa K, Kashima K. Side effects of high-dose interferon therapy for chronic hepatitis C. J Hepatol 1996; 25: 283-291
3. Horigome H, Takezono Y, Fujino N, Uchida A, Murasaki G. [A case of ischemic colitis associated with interferon treatment]. Nihon Shokakibyo Gakkai Zasshi 1996; 93: 181-184
4. Wenner WJ, Piccoli DA. Colitis associated with alpha interferon? J Clin Gastroenterol 1997; 25: 398-399
5. Punnam SR, Pothula VR, Gourineni N, Punnam A, Ranganathan V. Interferon-ribavirin-associated ischemic colitis. J Clin Gastroenterol 2008; 42: 323-325
6. Tada H, Saitoh S, Nakagawa Y, Hirana H, Morimoto M, Shima T, Shimamoto K, Okanoue T, Kashima K. Ischemic colitis during interferon-alpha treatment for chronic active hepatitis C. J Gastroenterol 1996; 31: 582-584
7. Leung Y, Urbanski SJ, Schindel L, Myers RP. Ischemic colitis during pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Can J Gastroenterol 2006; 20: 661-663
8. Gish RG, Lau DT, Schmid P, Perrillo R. A pilot study of extended duration peginterferon alfa-2a for patients with hepatitis B e antigen-negative chronic hepatitis B. Am J Gastroenterol 2007; 102: 2718-2723
9. Hehlmann R, Hochhaus A, Baccarani M. Chronic myeloid leukaemia. Lancet 2007; 370: 342-350
10. Sparano JA, Dutcher JP, Kaleya R, Caliendo G, Fiorito J, Mitsudo S, Shechner R, Boley SJ, Gucalp R, Ciobanu N. Colonic ischemia complicating immunotherapy with interleukin-2 and interferon-alpha. Cancer 1991; 68: 1538-1544
11. Ludwig H, Fritz E. Interferon in multiple myeloma--summary of treatment results and clinical implications. Acta Oncol 2000; 39: 815-821
12. Fried MW. Side effects of therapy of hepatitis C and their management. Hepatology 2002; 36: S237-S244
13. Sprenger R, Sagmeister M, Offner F. Acute ulcerative colitis during successful interferon/ribavirin treatment for chronic hepatitis. Gut 2005; 54: 438-439; author reply 439
14. Guyer DR, Tiedeman J, Yannuzzi LA, Slakter JS, Parke D, Kelley J, Tang RA, Marmor M, Abrams G, Miller JW. Interferon-associated retinopathy. Arch Ophthalmol 1993; 111: 350-356
15. Nadir A, Amin A, Chalisa N, van Thiel DH. Retinal vein thrombosis associated with chronic hepatitis C: a case series and review of the literature. J Viral Hepat 2000; 7: 466-470